ArticlePloS one2018

Change in plasma lactate concentration during arctigenin administration in a phase I clinical trial in patients with gemcitabine-refractory pancreatic cancer.

Rumi Fujioka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.